DRI vs LAB · P/E 22, rev $12.08B vs rev $174.4M
Darden Restaurants Inc (DRI) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
Darden Restaurants Inc (DRI) is a restaurants company listed on NYSE.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported DRI revenue for 2025-05-25 was $12.08B. Net income was $1.05B. Revenue was up 6.0% from 2024-05-26 to 2025-05-25. DRI currently screens at market cap $24.20B and trailing P/E 22.3.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
DRI currently screens at market cap $24.20B and trailing P/E 22.3. LAB currently screens at market cap $317.1M.
Not investment advice. Open the DRI and LAB stock pages for the full models.
Not investment advice.